Persistent Crude Oil Pressures, Weak Earnings Upgrades and Macroeconomic Risks Weigh on India's Market Outlook as Brokerage Warns of Limited Valuation Upside

Axis Bank Falls 4.5% After Q2 Results, Karur Vysya Bank Hits Record High, While Investors Track Earnings From Bajaj Finance, UltraTech Cement and Other Companies

Solara Active Pharma Sciences reported a consolidated net profit of ₹28.59 crore in Q2FY27, compared with a loss a year earlier, while first-half profit climbed to ₹44.70 crore.

Brent crude and WTI retreat in Friday’s trade after a recent rally, but uncertainty around the Strait of Hormuz, falling US inventories and geopolitical tensions continue to support prices; IEA diesel releases offer some relief to fuel markets.

Strong loan growth, lower credit costs and steady operating performance may support September-quarter earnings, while FCNR(B) deposit mobilisation could pull net interest margins down by 7–12 basis points

Long-term technical support attracts buying interest as IT stocks recover from July lows; HCL Tech shows improving momentum, while Zensar’s chart points to a possible move towards ₹555–580

Flights to and from Riyadh, Dammam and Jeddah remain suspended as security concerns escalate; affected passengers are eligible for full refunds, while other airlines extend their suspensions

Analysts expect healthy loan growth and strong net interest income to support earnings for India’s second-largest private-sector lender, while lower margins and higher provisions could temper the September-quarter performance

Strong Q2 FY27 business updates, festive demand, premiumisation and gains by organised jewellery retailers lift investor sentiment, while debt reduction and export expansion add company-specific triggers